Bausch + Lomb launched two preservative-free lubricating eye drops, Blink Nourish and Blink Boost, in the U.S., according to ...

The prevalence and severity of refractive and corneal astigmatism in children rose after the COVID-19 pandemic, according to ...

CHICAGO — Counties in the U.S. with the highest environmental burden, such as increased pollution, had significantly higher ...

Universal presumption of low-dose aspirin, instead of risk-based screenings, can increase uptake for preeclampsia prevention ...

Congress passing the controversial One Big Beautiful Bill Act could leave millions without insurance and lead to at least ...

International medical graduate hematology/oncology fellows demonstrate greater research productivity than American medical ...

At the Heart in Diabetes CME Conference, speakers highlighted four recent reports published in the Journal of the American ...

Adults with unresectable stage III or IV melanoma maintained similar progression-free disease control with 1- or 2-year ...

Relacorilant (Corcept Therapeutics), an investigational selective glucocorticoid receptor antagonist, in combination with nab-paclitaxel demonstrated PFS and OS benefit compared with nab-paclitaxel ...

In this video, Susana M. Campos, MD, MPH, discusses new data from the TRUST trial, which were presented at ASCO Annual Meeting.The trial compared primary cytoreductive surgery followed by chemotherapy ...

In this video, Susana M. Campos, MD, MPH, discusses results from a phase 2 trial of pembrolizumab and lenvatinib for patients with recurrent or persistent clear-cell ovarian cancer.Findings from the ...

In this video, Susana M. Campos, MD, MPH, discusses results from a phase 3 clinical trial of dostarlimab and niraparib in advanced ovarian cancer, presented at ASCO Annual Meeting.The FIRST/ENGOT-OV44 ...